(redirected from tissue-type plasminogen activator)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.


A map of a town or a section of land that has been subdivided into lots showing the location and boundaries of individual parcels with the streets, alleys, easements, and rights of use over the land of another.

A plat is usually drawn to scale.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.

PLAT. A map of a piece of land, in which are marked the courses and distances of the different lines, and the quantity of land it contains.
     2. Such a plat;nay be given in evidence in ascertaining the position of the land, and what is included, and may serve to settle the figure of a survey, and correct mistakes. 5 Monr. 160. See 17 Mass. 211; 5 Greenl. 219; 7 Greenl, 61; 4 Wheat. 444; 14 Mass. 149.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
References in periodicals archive ?
Angles-Cano, "Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen," European Journal of Biochemistry, vol.
Keywords: Unstable angina, Acute myocardial infarction, hsCRP, Coronary artery disease, tissue-type plasminogen activator, plasminogen activator inhibitor-1.
Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP.
Human tissue-type plasminogen activator synthesized by using a baculovirus vector in insect cells compared with human plasminogen activator produced in mouse cells.
Particularly important to the regulated production of plasmin are tissue-type plasminogen activator (tPA) [4] and urokinase plasminogen activator (uPA).
NSO produced a concentration-dependent inhibition of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor type 1 (PAI-1).
Clinical question Does primary angioplasty in myocardial infarction produce better long-term outcomes than tissue-type plasminogen activator (t-PA)?
[25.] Mizoi K, Yoshimoto T, Fujiwara S, Sugawara T, Takahashi A, Koshu K: Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: Preliminary report.
Amphoterin can interact with macrophage cell surface receptors for advanced glycation end products to enhance expression of tissue-type plasminogen activator (6).
The continuously high PAI-1 concentrations make fibrins resistant to dissolution by tissue-type plasminogen activator (tPA), which leads to multiorgan dysfunction and a bad prognosis in patients (2).
One unit of PAI-1 activity was defined as the amount that inhibited 1 IU of single tissue-type plasminogen activator in 15 min at room temperature under the conditions used.
On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.